Cargando…
“Tossing a coin:” defining the excessive use of short-acting beta(2)-agonists in asthma—the views of general practitioners and asthma experts in primary and secondary care
The National Review of Asthma Deaths (NRAD) identified high prescribing of short–acting beta(2)-agonists (SABAs) as a key factor in over 40% of deaths. We interviewed asthma experts from both a hospital background (n = 5) and a primary care background (n = 8), and general practitioners delivering as...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052065/ https://www.ncbi.nlm.nih.gov/pubmed/30022059 http://dx.doi.org/10.1038/s41533-018-0096-4 |